Table 3 Distribution of eGFR and SUA levels before and after frequency matching in the current study
Variables | Males | Females | P-value | |||
|---|---|---|---|---|---|---|
n = 417 | n = 571 | |||||
Before matching (n = 988) | eGFR (mL/min/1.73 m2) | 80.8 (42.9, 107.4) | 111.3 (71.9, 133.7) | < 0.001 | ||
eGFR group (n[%]) | < 60.0 | 139 (33.3) | < 60.0 | 95 (16.6) | < 0.001 | |
60.0–89.9 | 112 (26.9) | 60.0–89.9 | 98 (17.2) | |||
≥90.0 | 166 (39.8) | ≥90.0 | 378 (66.2) | |||
SUA (μmol/L) | 405 (343, 492) | 295 (239, 373) | < 0.001 | |||
SUA group (n[%]) | < 316 | 77 (19.4) | < 271 | 214 (40.3) | < 0.001 | |
316–419 | 145 (36.6) | 271–359 | 166 (31.3) | |||
420–524 | 100 (25.3) | 360–449 | 99 (18.6) | |||
525–629 | 56 (14.1) | 450–539 | 36 (6.8) | |||
≥630 | 18 (4.5) | ≥540 | 16 (3.0) | |||
Hyperuricaemia (n [%]) | 174 (43.9) | 148 (27.9) | < 0.001 | |||
After matching (n = 678) | n = 329 | n = 349 | ||||
eGFR (mL/min/1.73 m2) | 88.8 (59.0, 115.3) | 91.1 (61.0, 118.2) | 0.353 | |||
eGFR group (n [%]) | < 60.0 | 84 (25.5) | <60.0 | 83 (23.8) | 0.812 | |
60.0–89.9 | 83 (25.2) | 60.0–89.9 | 86 (24.6) | |||
≥90.0 | 162 (49.2) | ≥90.0 | 180 (51.6) | |||
SUA (μmol/L) | 400.0 (332.0, 469.0) | 328.0 (289.0, 404.0) | < 0.001 | |||
SUA group (n [%]) | < 316 | 67 (21.3) | < 271 | 59 (17.8) | 0.601 | |
316–419 | 118 (37.5) | 271–359 | 143 (43.2) | |||
420–524 | 88 (27.9) | 360–449 | 86 (26.0) | |||
525–629 | 33 (10.5) | 450–539 | 32 (9.7) | |||
≥630 | 9 (2.9) | ≥540 | 11 (3.2) | |||
Hyperuricaemia (n [%]) | 130 (41.3) | 126 (38.1) | 0.422 | |||